(NASDAQ: AHCO) Adapthealth's forecast annual revenue growth rate of 5.51% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Adapthealth's revenue in 2025 is $3,240,757,000.On average, 4 Wall Street analysts forecast AHCO's revenue for 2025 to be $436,922,896,777, with the lowest AHCO revenue forecast at $435,929,405,274, and the highest AHCO revenue forecast at $439,014,194,362. On average, 4 Wall Street analysts forecast AHCO's revenue for 2026 to be $462,668,302,966, with the lowest AHCO revenue forecast at $448,425,507,034, and the highest AHCO revenue forecast at $486,327,823,482.
In 2027, AHCO is forecast to generate $536,198,580,398 in revenue, with the lowest revenue forecast at $536,198,580,398 and the highest revenue forecast at $536,198,580,398.